Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David B. Banks"'
Autor:
Lindsey M. Ludwig, Katrina M. Hawley, David B. Banks, Anika T. Thomas-Toth, Bruce R. Blazar, Megan E. McNerney, Joel D. Leverson, James L. LaBelle
Publikováno v:
Cell Death and Disease, Vol 12, Iss 11, Pp 1-13 (2021)
Abstract BH3 mimetics are increasingly used as anti-cancer therapeutics either alone or in conjunction with other chemotherapies. However, mounting evidence has also demonstrated that BH3 mimetics modulate varied amounts of apoptotic signaling in hea
Externí odkaz:
https://doaj.org/article/d84afd72b45847c7ad624cf81eb78fc7
Autor:
April K Binder, Danielle L Peecher, Amanda J Qvigstad, Silvia D Gutierrez, Jennifer Magaña, David B Banks, Kenneth S Korach
Publikováno v:
Endocrinology
Several mouse models have been developed to study polycystic ovarian syndrome (PCOS), a leading cause of infertility in women. Treatment of mice with DHT for 90 days causes ovarian and metabolic phenotypes similar to women with PCOS. We used this 90-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d62a000626579f9ed87ce1af2db637
https://europepmc.org/articles/PMC10208753/
https://europepmc.org/articles/PMC10208753/
Autor:
David B. Banks, Gary N.Y. Chan, David S. Miller, Emily V. Mesev, Ronald E. Cannon, Rebecca A Evans
Publikováno v:
Neuroscience Letters. 639:103-113
P-glycoprotein (P-gp), Breast cancer resistance protein (BCRP) and Multidrug resistance-associated protein 2 (MRP2) residing at the blood-brain barrier (BBB) and the blood-spinal cord barrier (BSCB) are major obstacles for drug delivery to the Centra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7fa4fc0f681fbdbbe0cfe0f45e5a27
https://doi.org/10.1016/j.neulet.2016.12.049
https://doi.org/10.1016/j.neulet.2016.12.049
Publikováno v:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 38(5)
The blood–brain barrier is a microvascular network that (1) provides neuroprotection from metabolic and environmental toxins and (2) limits the delivery of therapeutics to the central nervous system (CNS). The ATP-binding cassette transporter P-gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebb0456df5deb4d2fd138a02bdb8d03
https://pubmed.ncbi.nlm.nih.gov/28447863
https://pubmed.ncbi.nlm.nih.gov/28447863